These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21223509)

  • 1. Percutaneous catheter-based intracoronary infusion of insulin--a dose finding study in the porcine model.
    Slettom G; Jonassen AK; Tuseth V; Pettersen RJ; Larsen TH; Seifert R; Nordrehaug JE
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):414-20. PubMed ID: 21223509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.
    Zhang HX; Zang YM; Huo JH; Liang SJ; Zhang HF; Wang YM; Fan Q; Guo WY; Wang HC; Gao F
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):306-13. PubMed ID: 17204910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
    Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
    Timmers L; Henriques JP; de Kleijn DP; Devries JH; Kemperman H; Steendijk P; Verlaan CW; Kerver M; Piek JJ; Doevendans PA; Pasterkamp G; Hoefer IE
    J Am Coll Cardiol; 2009 Feb; 53(6):501-10. PubMed ID: 19195607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction.
    Bucciarelli-Ducci C; Bianchi M; De Luca L; Battagliese A; Di Russo C; Proietti P; Vizza CD; Fedele F
    Am J Cardiol; 2006 Nov; 98(10):1349-53. PubMed ID: 17134627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
    Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
    Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Grygier M; Araszkiewicz A; Lesiak M; Janus M; Kowal J; Skorupski W; Pyda M; Mitkowski P; Grajek S
    Am J Cardiol; 2011 Apr; 107(8):1131-5. PubMed ID: 21310372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary adiponectin at reperfusion reduces infarct size in a porcine myocardial infarction model.
    Dębiński M; Buszman PP; Milewski K; Wojakowski W; Jackiewicz W; Pająk J; Szurlej D; Fryc-Stanek J; Wiernek S; Jelonek M; Spurlock ME; Martin J; Bochenek A; Buszman PE
    Int J Mol Med; 2011 Jun; 27(6):775-81. PubMed ID: 21399860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by L-glutamate during postischaemic reperfusion: reduced infarct size and enhanced glycogen resynthesis in a rat insulin-free heart model.
    Kristiansen SB; Løfgren B; Støttrup NB; Kimose HH; Nielsen-Kudsk JE; Bøtker HE; Nielsen TT
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):884-8. PubMed ID: 18346179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.
    Stone GW; Martin JL; de Boer MJ; Margheri M; Bramucci E; Blankenship JC; Metzger DC; Gibbons RJ; Lindsay BS; Weiner BH; Lansky AJ; Krucoff MW; Fahy M; Boscardin WJ;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):366-75. PubMed ID: 20031745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
    Malmberg K; Rydén L
    Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats.
    Dikow R; Wasserhess C; Zimmerer K; Kihm LP; Schaier M; Schwenger V; Hardt S; Tiefenbacher C; Katus H; Zeier M; Gross LM
    Basic Res Cardiol; 2009 Sep; 104(5):571-9. PubMed ID: 19288152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic efficacy of pulmonary delivered insulin dry powder aerosol in rats.
    Chen XJ; Zhu JB; Wang GJ; Zhou MX; Xin FM; Zhang N; Wang CX; Xu YN
    Acta Pharmacol Sin; 2002 May; 23(5):467-70. PubMed ID: 11978199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins.
    George E; Bedford C; Peacey SR; Hardisty CA; Heller SR
    Diabet Med; 1997 Jun; 14(6):442-8. PubMed ID: 9212308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin Postconditioning Reduces Infarct Size in the Porcine Heart in a Dose-Dependent Manner.
    Slettom G; Jonassen AK; Dahle GO; Seifert R; Larsen TH; Berge RK; Nordrehaug JE
    J Cardiovasc Pharmacol Ther; 2017 Mar; 22(2):179-188. PubMed ID: 27390144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of insulin therapy following acute myocardial infarction revisited.
    Soran H; Barzangy B; Younis N
    QJM; 2006 Sep; 99(9):635-7. PubMed ID: 16921196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.